The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaLucy C. Fox, Andrew Grigg, Katherine D. Cummins et al.|Blood Advances|2017Cited by 42
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemiaAdrian Minson, Andrew Grigg, Katherine D. Cummins et al.|Blood Advances|2019Cited by 26
Proliferative Glomerulonephritis With Fibrils, Monoclonal κ Light Chain, and C3 DepositsAdam Steinberg, Thomas Barbour, Guy Touchard et al.|American Journal of Kidney Diseases|2021Cited by 4